+ Site Statistics
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Resistance against Trypanosoma cruzi associated to anti-living trypomastigote antibodies

Resistance against Trypanosoma cruzi associated to anti-living trypomastigote antibodies

Journal of Immunology 128(5): 2009-2012

A dissociation between antibodies involved in the diagnosis of Trypanosoma cruzi infections and those participating in resistance against this parasite is reported. Mice immunized with different T. cruzi antigens (frozen-thawed culture forms, glutaraldehyde-fixed blood trypomastigotes, "metabolic antigens" from blood parasites, and surface glycoprotein from epimastigotes) present only antibodies detected by conventional immunofluorescence tests (IFA) using fixed parasites. However, mice chronically infected with T. cruzi harbor both reactive IFA antibodies and antibodies against living blood forms (ALBA) detectable by complement-mediated lysis (CML). Challenge of the various groups of animals with virulent T. cruzi show that only mice presenting ALBA are strongly resistant. In addition, the antibody lytic activity is lost in mice parasitologically cured after specific treatment. Those findings strongly suggest that ALBA are good markers for monitoring protection in experiments of vaccination against T. cruzi. They also support our previous suggestion that the search for antibodies against living blood forms, detected mainly by CML, is an important element in establishing a reliable criterion of cure in human Chagas' disease.

(PDF emailed within 1 workday: $29.90)

Accession: 000969667

Download citation: RISBibTeXText

PMID: 6801127

Related references

The utility of anti-trypomastigote lytic antibodies for determining cure of Trypanosoma cruzi infections in treated patients: an overview and perspectives. Memorias do Instituto Oswaldo Cruz 104 Suppl 1: 142-151, 2010

Innovations in diagnosis and post-therapeutic monitoring of Chagas disease: Simultaneous flow cytometric detection of IgG1 antibodies anti-live amastigote, anti-live trypomastigote, and anti-fixed epimastigote forms of Trypanosoma cruzi. Journal of Immunological Methods 413: 32-44, 2015

Isolation of the trypomastigote form of Trypanosoma cruzi from a mixture of the trypomastigote and epimastigote forms of the parasite by use of a DEAE-cellulose column. Journal of Parasitology 58(3): 631-632, 1972

Identification of monoclonal antibodies against the trypomastigote state of trypanosoma cruzi by use of iminobiotinylated surface polypeptides. Molecular & Biochemical Parasitology 16(2): 199-212, 1985

Immunity against infection with trypanosoma cruzi in mice correlates with presence of antibodies against 3 trypomastigote polypeptides. Infection & Immunity 46(3): 826-830, 1984

Immunity against infection with Trypanosoma cruzi in mice correlates with presence of antibodies against three trypomastigote polypeptides. Infection and Immunity 46(3): 826-830, 1984

A monoclonal antibody recognizes a trypanosoma cruzi trypomastigote stage specific epitope on the trypomastigote 83 kda required for parasite attachment to host cells. FASEB Journal 6(5): A1797, 1992

The reactivity and lytic properties of two monoclonal antibodies against metacyclic trypomastigote of trypanosoma cruzi a survey of 11 strains. Memorias do Instituto Oswaldo Cruz 82(SUPPL 1): 135, 1987

Induction of capping in blood-stage trypomastigotes of Trypanosoma cruzi by human anti-Trypanosoma cruzi antibodies. Infection and Immunity 20(2): 567-569, 1978

Protective antibodies in Trypanosoma cruzi infections: detection, functional activity and possible mechanisms of trypomastigote killing in vivo and in vitro. Memorias do Instituto Oswaldo Cruz 79(Special Issue Suppl.): 59-65, 1984

Complement mediated lysis of trypomastigote forms of trypanosoma cruzi by human antibodies with an affinity for sialic acid containing glycoconjugates. Memorias do Instituto Oswaldo Cruz 82(SUPPL 1): 142, 1987

Complement mediated lysis of trypanosoma cruzi trypomastigote forms by human antibodies with affinity for alpha d galactopyranose containing glycoconjugates. Memorias do Instituto Oswaldo Cruz 81(SUPPL): 116, 1986

Partial inhibition of trypomastigote entry into cultured mammalian cells by monoclonal antibodies against a surface glycoprotein of Trypanosoma cruzi. Molecular and Biochemical Parasitology 21(1): 75-82, 1986